The report will be delivered in 2-3 business days.

Anti-Infective Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 300 | Published : January 2019 | SKU CODE : 5282 | Format :


Anti-Infective Drugs Market Characteristics

The anti-infective drugs market consists of sales of anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce anti-infective drugs to treat microbial infections. This industry includes establishments that produce antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti- helminthic drugs to kill internal parasites and antiprotozoal agents.

Competitive Landscape of the Anti-Infective Drugs Market

Major players in the global Anti-infective drugs market include Gilead, Merck & Co, GlaxosmithKline, Bristol-Myers Squibb Company, Johnson & Johnson

Anti-Infective Drugs Market Size

The anti-infective drugs market size is expected to reach $130 billion by 2022, significantly growing at a CAGR of around 3% during the forecast period. The growth in the Anti-infective drugs market is mainly due to the growing infectious diseases caused by bacteria, viruses, fungi and the expected increase in global healthcare expenditure.

However, the market for Anti-infective drugs is expected to face certain restraints from several factors such as increasing government regulation and changing shift towards ayurvedic treatment.

Anti-Infective Drugs Market Segmentation

The global anti-infective drugs market is further segmented based on type and geography.
By Type - The anti-infective drugs market is segmented into antibiotics, antivirals, antifungals, others (anthelminthic, antiprotozoal) among these segments, the antibiotics market accounts for the largest share in the global Anti-infective drugs market.
By Geography - The global anti-infective drugs is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global anti-infective drugs market.
Trends in the Anti-Infective Drugs Market
Companies in this market are active with multiple strategic collaborations and agreements. Top companies in the anti-infective drug market are strategically partnering and collaborating with other companies to broaden their products and services. For instance, in May 2015, Janssen Pharmaceuticals Inc., subsidiary of Johnson & Johnson has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals Inc. to develop and commercialize one or more of Achillion`s lead hepatitis C virus (HCV) assets which include ACH-3102, ACH-3422 and sovaprevir . Also in December 2017, Evotec AG was in a strategic alliance with Forge Therapeutics Inc. to advance its novel Gram-negative antibiotic programme targeting `LpxC` for the treatment of bacterial infections. Chimerix and ContraVir Pharmaceuticals also entered into a strategic collaboration for antiviral drug candidate CMX157 Potential Opportunities in the Anti-Infective Drugs Market This slight growth can be attributed to the prevalence of diseases such as HIV/AIDS, hepatitis, Ebola, flu caused by viral infections and increased global healthcare expenditure the global anti-infective drugs market is expected to significantly rise in the forecast period.

No Related Insights
Global Biologics Market, Opportunities And Strategies To 2021
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Anti-Infective Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)